Astec Lifesciences informs about outcome of board meeting

29 Oct 2022 Evaluate
Astec Lifesciences has informed that the Board of Directors of the Company, at its Meeting held on Friday, 28th October, 2022, has approved the Unaudited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2022. It enclosed a copy of the Press Release and the same is being placed on the website of the Company, www.astecls.com 

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

1216.80 -25.80 (-2.08%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
UPL 508.50
BASF India 3714.95
PI Industries 3768.05
Bayer CropScience 5546.75
Sumitomo Chemical India 406.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.